Platelet substitutes and novel platelet products

Bibliography

• MURPHY S: Platelet storage for transfusion. Semin. Hematol. (1985) 22:165–177.
   PubMed Web of Science ®Google Scholar
• MOROFF G, HOLME S: Concepts about current storage conditions for the preparation and storage of platelets. Transf Med. Rev. (1991) 5:48–59.
   PubMedGoogle Scholar
• CARMEN R: The selection of plastic materials for blood bags. Transf Med. Rev. (1993) 7:1–10.
   PubMedGoogle Scholar
• BORDIN JO, HEDDLE NM, BLAJCHMAN MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood (1994) 84:1703–1721.
   PubMed Web of Science ®Google Scholar
• HEDDLE NM, KLAMA LN, GRIFFITH L, ROBERTS R, SHUKLA G, KELTON JG: A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion (1993) 33:794–797.
   PubMed Web of Science ®Google Scholar
• BLAJCHMAN MA: Bacterial contamination and prolif-eration during the storage of cellular blood products. Vox Sang. (1998) 74 (Suppl. 2):155–159.
   Google Scholar
• SLICHTER SJ: Platelet refractoriness and alloimmuniza-don. Leukaemia (1998) 12 (Suppl. 1):S51–S53.
   Google Scholar
• NOVOTNY VM: Prevention and management of platelet transfusion refractoriness. Vox Sang. (1999) 76:1–13.
   PubMed Web of Science ®Google Scholar
• ORLIN JB, ELLIS MH: Transfusion-associated graft-versus-host disease. Curr. Opin. Hematol. (1997) 4:442–448.
   PubMedGoogle Scholar
• BLAJCHMAN MA: Immunomodulatory effects of alloge-neic blood transfusions: Clinical manifestations and mechanisms. Vox Sang. (1998) 74 (Suppl. 2):315–319.
   Google Scholar
• MELARAGNO AJ, CARCIERO R, FEINGOLD H, TALARICO L, WEITRAUB L, VALERI CR: Cryopreservation of human platelets using 6% dimethyl sulfoxide and storage at -80°C. Vox Sang. (1985) 49:245–258.
   PubMed Web of Science ®Google Scholar
• CURRIE LM, LIVESEY SA, HARPER JR, CONNOR J: Cryopreservation of single-donor platelets with a reduced dimethyl sulfoxide concentration by the addition of second-messenger effectors: Enhanced retention of in vitro functional activity. Transfusion (1998) 38:160–167.
   PubMed Web of Science ®Google Scholar
• CURRIE LM, LICHTIGER B, LIVESEY SA, TANSEY W, YANG DJ, CONNOR J: Enhanced circulatory parameters of human platelets cryopreserved with second-messenger effectors: An in vivo study of 16 volunteer platelet donors. Br. J. Haematol. (1999) 105:826–831.
   PubMed Web of Science ®Google Scholar
• ALVING BM, REID TJ, FRATANTONI JC, FINLAYSON JS: Frozen platelets and platelet substitutes in transfusion medicine. Transfusion (1997) 37:866–876.
   PubMed Web of Science ®Google Scholar
• REID TJ, GAO D: Symposium on cryopreservation of human platelets: An overview. Cryobiology (1999) 38:177–179.
   PubMedGoogle Scholar
• MURPHY S, GARDNER FH: Platelet Preservation. Effectof temperature on maintenance of platelet viability - Deleterious effect of refrigerated storage. N Engl. J. Med. (1969) 280:1094–1098.
   Google Scholar
• SLICHTER SJ, HARKER LA: Preparation and storage ofplatelet concentrates II. Storage variables influencing platelet viability and function. Br. J. Haematol. (1976) 34:403–419.
   Google Scholar
• FILIP DJ, ASTER RH: Relative hemostatic effectiveness of platelets stored at rand 22°C. J. Lab. Clin. Med. (1978) 91:618–624.
   PubMed Web of Science ®Google Scholar
• VOSTAL JG, MONDORO TH: Liquid cold storage of platelets: A revitalized possible alternative for limiting bacterial contamination of platelet products. Transfus. Med. Rev. (1997) 11:286–295.
   PubMed Web of Science ®Google Scholar
• WINOKUR R, HARTWIG JH: Mechanism of shape change in chilled human platelets. Blood (1995) 85:1796–1804.
   PubMed Web of Science ®Google Scholar
• CONNOR J, CURRIE LM, ALLAN H, LIVESAY SA: Recovery of in vitro functional activity of platelet concentrates stored at 4 degrees C and treated with second-messenger effectors. Transfusion (1996) 36:691–698.
   PubMed Web of Science ®Google Scholar
• RIVERA J, LOZANO ML, CORRAL J et al.: Quality assess-ment of platelet concentrates supplemented with second-messenger effectors. Transfusion (1999) 39:135–143.
   PubMed Web of Science ®Google Scholar
• CORASH L: Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: Current research perspectives. Transf Med. Rev. (1999) 13:18–30.
   PubMed Web of Science ®Google Scholar
• WOLF P: The nature and significance of platelet products in human plasma. Br. J. Haematol. (1967) 13:269–288.
   PubMed Web of Science ®Google Scholar
• OWENS M: The role of platelet microparticles in hemostatis. Transf Med. Rev. (1994) 8:37–44.
   PubMed Web of Science ®Google Scholar
• SOLBERG C, HOLME S, LITTLE C: Morphological changes associated with pH changes during storage of platelet concentrates in first-generation 3-day container. Vox Sang. (1986) 50:71–77.
   PubMed Web of Science ®Google Scholar
• GEORGE JN, PICKETT EB, HEINZ R: Platelet membrane glycoportein changes during the preparation and storage of platelet concentrates. Transfusion (1988) 28:123–126.
   PubMed Web of Science ®Google Scholar
• BODE AP, ORTON SM, FRYE MJ, UDIS BJ: Vesiculation of platelets during in vitro aging. Blood (1991) 77:887–895.
   PubMed Web of Science ®Google Scholar
• GEORGE JN, PICKETT EB, HEINZ R: Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood (1986) 68:307–309.
   PubMed Web of Science ®Google Scholar
• SOLBERG S, OSTERUD B, LITTLE C: Platelet storage lesion: Formation of platelet fragments with platelet factor 3 activity. Thromb. Res. (1987) 48:559–565.
   PubMed Web of Science ®Google Scholar
• BODE AP, MILLER DT: Analysis of platelet factor 3 in platelet concentrates stored for transfusion. Vox Sang. (1986) 51:299–305.
   PubMed Web of Science ®Google Scholar
• OWENS MR, HOLME S, CARDINALI S: Platelet microvesi-cies adhere to subendothelium and promote adhesion of platelets. Thromb. Res. (1992) 66:247–258.
   PubMed Web of Science ®Google Scholar
• HJORT PF, PERMAN V, CRONKITE EP: Fresh, disinte-grated platelets in adiation thrombocytopenia: Correction of prothrombin consumption without correction of bleeding. Proc. Soc. Exp. Biol. Med. (1959) 102:31–35.
   PubMed Web of Science ®Google Scholar
• MCGILL M, FUGMAN DA, VITTORIO N, DARROW C: Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits. J. Lab. Clin. Med. (1987) 109:127–133.
   PubMedGoogle Scholar
• CHAO FC, KIM BK, HOURANIEH AM et al.: Infusibleplatelet membrane microvesicles: A potential transfu-sion substitute for platelets. Transfusion (1996) 36:536–542.
   PubMed Web of Science ®Google Scholar
• GRAHAM SS, GONCHOROFF NJ, MILLER JL: Characteriza-tion of von Willebrand factor binding to infusible platelet membranes. Blood (1998) 92 (Suppl. 1):132b.
   Google Scholar
• GOODNOUGH LT, KOLODZIEJ M, EHLENBECK C: A Phase I study of safety and efficacy for infusible platelet membrane in patients. Blood (1995) 86\(Suppl. 1):610a.
   Google Scholar
• SCIGLIANO E, ENRIGHT H, TELEN M et al.: Infusibleplatelet membrane for control of bleeding in thrombocytopenic patients. Blood (1997) 90\(Suppl. 1):267a.
   Google Scholar
• KLEIN E, FARBER S, DJERASSI I, TOCH R, FREEMAN G,ARNOLD P: The preparation and clinical administra-tion of lyophilised platelet material to children with acute leukaemia and aplastic anemia. J. Pediatrics (1956) 49:517–522.
   PubMed Web of Science ®Google Scholar
• STEFANINI M, KISTNER S: Use of platelet derivatives andplatelet substitutes in the management of thrombocy-topenic states. Clin. Res. Proc. (1957) 5:151–152.
   Google Scholar
• FLIEDNER TM, SORENSEN DK, BOND VP, CRONKITE EP,JACKSON DP, ADAMIK E: Comparative effectiveness of fresh and lyophilised platelets in controlling irradia-tion hemorrhage in the rat. Proc. Soc. Exp. Biol. Med. (1958) 99:731–733.
   PubMed Web of Science ®Google Scholar
• JACKSON DP, SORENSEN DK, CRONKITE EP, BOND VP,FLIEDNER TM: Effectiveness of transfusions of fresh and lyophilised platelets in controlling bleeding due to thrombocytopenia. j Clin. Invest. (1959) 38:1689–1697.
   PubMed Web of Science ®Google Scholar
• READ MS, REDDICK RL, BODE AP et al.: Preservation of hemostatic and structural properties of rehydrated lyophilised platelets: Potential for long-term storage of dried platelets for transfusion. Proc. Natl. Acad. Sci. USA (1995) 92:397–401.
   PubMed Web of Science ®Google Scholar
• BODE AP: Preclinical testing of lyophilised platelets as a product for transfusion medicine. Transfus. Sci. (1995) 16:183–185.
   PubMedGoogle Scholar
• SANDERS WE, KHANDEL WAL G, BELLINGER DA, BODEAP, READ MS: Fibrinogen binding to rehydrated lyophilised platelet surface GPIlb-Ifia: Normal clot formation and tPA lysis. Blood (1996) 88\(Suppl. 1):30a.
   Google Scholar
• REID TJ, SNIDER R, HARTMAN K, GREILICH PE, CARR ME,ALVING BM: A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets. VoxSang. (1998) 75:270–277.
   Google Scholar
• SEAMAN WT, NICHOLS TC, READ MS: Rehydrated lyophilised platelets retain GPlb receptors capable of interacting with the Al loop of von Willebrand factor. Blood (1997) 90 (Suppl. 2):72b.
   Google Scholar
• BRINKHOUS KM, READ MS: Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophili-zation: New stable platelet preparations for von Willebrand assays. Thromb. Res. (1978) 13:591–597.
   PubMed Web of Science ®Google Scholar
• READ MS, KHANDEL WAL G, MILLER RS, TAYLOR KK, BODE AP: Rehydrated lyophilised platelets: A proposed mechanism contributing to the hemostatic action. Blood (1995) 86 (Suppl. 1):907a.
   Google Scholar
• LEMANY M, HERNANDEZ MR, BOZZO J et al.: In vitro evaluation of the hemostatic effectiveness of non-viable platelet preparations: Studies with frozen-thawed, sonicated, or lyophilised platelets. Vox Sang. (1997) 73:36–42.
   PubMed Web of Science ®Google Scholar
• BODE AP, READ MS, REDDICK RL: Activation and adherence of lyophilised human platelets on canine vessel strips in the Baumgartner perfusion chamber. J. Lab. Clin. Med. (1999) 133:200–211.
   PubMed Web of Science ®Google Scholar
• BODE AP, LUST RM, READ MS: Lyophilised platelets correct the bleeding time test in a canine model of cardiopulmonary bypass. Thromb. Haemost. (1997) 77 (Suppl.):63.
   Google Scholar
• BODE AP, BLAJCHMAN MA, BARDOSSY L, READ MS: Hemostatic properties of human lyophilised platelets in a thrombocytopenic rabbit mode and a simulated bleeding time device. Blood (1994) 84\(Suppl. 1):464a.
   Google Scholar
• BLAJCHMAN MA, LEE DH: The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes. Transf Med. Rev. (1997) 11:95–105.
   PubMed Web of Science ®Google Scholar
• CHOI ES, NICHOL JL, HOKOM MM, HORNKOHL AC, HUNT P: Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood (1995) 85:402–413.
   PubMed Web of Science ®Google Scholar
• COLLER BS: Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: Defective platelet-fibrinogen interactin in thrombasthenia. Blood (1980) 55:169–178.
   PubMed Web of Science ®Google Scholar
• AGAM G, LIVNE A: Passive participation of fixed platelets in aggregation facilitated by covalently bound fibrinogen. Blood (1983) 61:186–191.
   PubMed Web of Science ®Google Scholar
• AGAM G, LIVNE A: Platelet-platelet recognition during aggregation: Distinct mechanisms determined by the release reaction. Thromb. Haemost. (1984) 51:145–149.
   PubMed Web of Science ®Google Scholar
• AGAM G, LIVNE A: Resolution and reconstitution of interplatelet recognition during aggregation. Thromb. Haemost. (1988) 59:504–506.
   PubMed Web of Science ®Google Scholar
• COMFURIUS P, SENDEN JMG, TILLY RHJ, SCHROIDT AJ, BEVERS EM, ZWAAL RFA: Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of amino-phospholipid translocase. Biochem. Biophys. Acta. (1990) 1026:153–160.
   PubMed Web of Science ®Google Scholar
• BEVERS EM, WIEDMER T, COMFURIUS P et al. Defective Ca (2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes form a patient with a bleeding disorder: A study of the red blood cells of Scott Syndrome. Blood (1992) 79:380–388.
   PubMed Web of Science ®Google Scholar
• WEISS HJ: Flow-related platelet deposition on subendo-thelium. Thromb. Haemost. (1995) 74:117–122.
   PubMed Web of Science ®Google Scholar
• AGAM G, LIVNE AA: Erythrocytes with covalently bound fibrinogen as a cellular replacement for the treatment of thrombocytopenia. Eur. J. Clin. Invest. (1992) 22:105–112.
   PubMed Web of Science ®Google Scholar
• COLLER BS, SPRINGER KT, BEER JH et al.: Thromboeryth-rocytes: In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. J. Clin. Invest. (1992) 89:564–565.
   Google Scholar
• BEER JH, SPRINGER KT, COLLER BS: Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoproteins fib/Ifia receptor. Blood (1992) 79:117–128.
   PubMed Web of Science ®Google Scholar
• CERASOLI F, WOOD S, REICHERT J et al.: Thromboeryth-rocytes reduce prolonged ear bleeding time in thrombocytopenic guinea pigs. Blood (1994) 84 (Suppl. 1):465a.
   Google Scholar
• LEVI M, FRIEDERICH PW, MIDDLETON S et al.: Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits. Nature Med. (1999) 5:107–111.
   PubMed Web of Science ®Google Scholar
• PERKINS AC, FRIER M, HINDLE AJ et al.: Human biodistri-bution of an ultrasound contrast agent (Quantison) by radiolabelling and gamma scintigraphy. Br. J. Radio]. (1997) 70:603–611.
   PubMed Web of Science ®Google Scholar
• YEN RCK, HO TWC, BLAJCHMAN MA: A new hemostatic agent: Thrombospheres shorten the bleeding time in thrombocytopenic rabbits. Thromb. Haemost. (1995) 73 (Suppl.):986.
   Google Scholar
• YEN RCK, HO TWC, BLAJCHMAN MA: A novel approach to correcting the bleeding associated with thrombocy-topenia. Transfusion (1995) 35 (Suppl.):41S.
   Google Scholar
• SIE P, GILLOIS M, BONEU B, CHAP H, BIERME R, DOUSTE-BLAZY L: Reconstitution of liposomes bearing platelet receptors for human von Willebrand factor. Biochem. Biophys. Res. Commun. (1980) 97:133–138.
   PubMed Web of Science ®Google Scholar
• BALDASSARE JJ, KAHN RA, KNIPP MA, NEWMAN PJ: Reconstitution of platelet proteins into phospholipid vesicles - Functional proteoliposomes. j Clin. Invest. (1985) 75:35–39.
   PubMed Web of Science ®Google Scholar
• PARISE LV, PHILLIPS DR: Platelet membrane glycopro-teins Ilb-Ifia complex incorporated into phospholipid vesicles. J. Biol. Chem. (1985) 260:1750–1756.
   PubMed Web of Science ®Google Scholar
• RYBAK ME: Glycoproteins fib and Ma and platelet thrombospondin in a liposome model of platelet aggregation. Thromb. Haemost. (1986) 55:240–245.
   PubMed Web of Science ®Google Scholar
• RYBAK ME, RENZULLI LA: A liposome based platelet substitute, the plateletsome with hemostatic efficacy. Biomater. Artif. Cells ImmobiL BiotechnoL (1993) 21:101–118.
   PubMed Web of Science ®Google Scholar
• NISHIYA T, MURATA M, HANDA M, IKEDA Y: Adhesion ofliposomes carrying a recombinant fragment of © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (2000) 9(3) platelet glycoproteins lb or anti-collagen antibody to collagen surface under flow conditions - Approach to platelet substitutes. Blood (1998) 92 (Suppl. 1):346–347.
   Google Scholar
• NI HY, GILES AR: Normalization of the haemostatic plugs of dogs with hemophilia A (Factor VIII deficiency) following the infusion of a combination of Factor Xa and phosphatidylcholine/phosphati-dylserine vesicles. Thromb. Haemost. (1992) 67:264–271.
   PubMed Web of Science ®Google Scholar
• GALAN AM, HERNANDEZ MR, BOZZO J et al: Prepara-tions of synthetic phospholipids promote procoagu-lant activity on damaged vessels: Studies under flow conditions. Transfusion (1998) 38:1004–1010.
   PubMed Web of Science ®Google Scholar
• RODGERS RPC, LEVIN J: A critical reappraisal of the bleeding time. Sem. Thromb. Hemost. (1990) 16:1–20.
   Web of Science ®Google Scholar
• SLICHTER SJ, HARKER LA: Thrombocytopenia: Mechanisms and management of defects in platelet production. Clin. Hematol (1978) 7:523–539.
   PubMedGoogle Scholar
• WOODS MC, GAMBLE FN, FURTH J, BIGELOW RR: Control of the post-irradiation hemorrhagic state by platelet transfusions. Blood (1953) 8:545–553.
   PubMed Web of Science ®Google Scholar
• BLAJCHMAN, MA: Substitutes for success. Nature Med. (1999) 5:17–18.
   PubMed Web of Science ®Google Scholar
• PROW D, VADHAM-RAJ S: Thrombopoietin: Biology and potential clinical applications. Oncology (1998) 12:1597–1604.
   PubMed Web of Science ®Google Scholar